- 【Updated on November 17, 2025】 Integration of CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on November 26, 2025】Regarding the recording of “Research Data” and “Evidence Data”
- CiNii Research researchers search function has been released.
- Regarding the suspension of updates to the "BOOK" database data
Serum metallomics of inflammation model mice and anti-inflammatory effects of selenium-containing compounds
-
- YOGIASHI Shunsuke
- Laboratory of Molecular Biology and Metabolism, Graduate School of Pharmaceutical Sciences, Tohoku University
-
- SHIMIZU Misaki
- Laboratory of Molecular Biology and Metabolism, Graduate School of Pharmaceutical Sciences, Tohoku University
-
- TOYAMA Takashi
- Laboratory of Molecular Biology and Metabolism, Graduate School of Pharmaceutical Sciences, Tohoku University
-
- YAZAKI Masana
- Graduate School of Bioresource and Bioenvironmental Sciences, Kyushu University
-
- ARISAWA Mieko
- Graduate School of Bioresource and Bioenvironmental Sciences, Kyushu University
-
- SAITO Yoshiro
- Laboratory of Molecular Biology and Metabolism, Graduate School of Pharmaceutical Sciences, Tohoku University
Bibliographic Information
- Other Title
-
- 炎症モデルマウスの血清メタロミクス解析およびセレン含有化合物の抗炎症作用の解析
Description
<p>Inflammation is closely related to trace elements in blood, and selenium has been reported to be inversely correlated with COVID-19 severity. There is a close relationship between antioxidant and anti-inflammatory effects, and the selenium-containing antioxidant Ebselen suppresses the inflammatory response associated with influenza. Here we sought to identify target elements for suppressing inflammation by metallomics of LPS-treated mice and to develop new anti-inflammatory drugs focusing on selenium.Serum metallomics analysis of LPS-treated mice revealed a strong correlation between cytokine expression in the liver and changes in serum trace elements such as zinc, copper, selenium, and potassium. In addition, we found that inflammation decreased GPx1 expression in the liver and that high-dose LPS administration decreased serum selenium, suggesting that selenium may be a target for anti-inflammatory drugs. Using a coupling assay with hydrogen peroxide and lipid hydroperoxide, we measured the antioxidant activity of new selenium-containing compounds. We found 3 compounds with strong antioxidant activity. These compounds inhibited cell death induced by oxidative stresses. These compounds showed not only their own antioxidant activity but also induction of antioxidant factor GPx1. The antioxidant activity of compounds contributed to anti-inflammatory effects, and the expression of cytokines was reduced. In mice, these compounds also showed a tendency to suppress inflammation. In conclusion, these selenium compounds are the potential candidates for anti-inflammatory drugs.</p>
Journal
-
- Annual Meeting of the Japanese Society of Toxicology
-
Annual Meeting of the Japanese Society of Toxicology 52.1 (0), P-49S-, 2025
The Japanese Society of Toxicology
- Tweet
Details 詳細情報について
-
- CRID
- 1390587528330715904
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
-
- Abstract License Flag
- Disallowed